Case Report: Multiple Organ Failure Caused by Hemorrhagic Fever with Renal Syndrome.
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
05 07 2023
05 07 2023
Historique:
received:
03
02
2023
accepted:
21
03
2023
pmc-release:
01
07
2024
medline:
7
7
2023
pubmed:
16
5
2023
entrez:
15
5
2023
Statut:
epublish
Résumé
Hemorrhagic fever with renal syndrome (HFRS), a natural epidemic disease caused by hantavirus (HV), is one of the viral diseases that pose a major threat to our health. Considering the increasing number of atypical-onset cases reported in some countries, it is important to be familiar with the symptoms of HFRS and the signs of HV infection. This report describes the case of a 55-year-old man with complaints of fever, vomiting, and diarrhea. His symptoms showed no significant improvement after routine anti-infective, antipyretic, and other symptomatic supportive treatments administered at a local clinic. During these treatments, the patient had progressive oliguria; after 3 days, he also developed multiple organ failures, such as the liver and kidney, and was examined for positive serum IgM antibodies to hemorrhagic fever during treatment at our hospital. The patient was finally diagnosed with HFRS followed by multiple organ failure. After antiviral therapy, including ribavirin, piperacillin, and tazobactam, continuous renal replacement therapy, fluid metabolism adjustment, and related supportive therapy were administered, which improved his liver and kidney function. He was discharged on the 25th day after hospitalization. It is difficult to manage patients who develop multiple organ failure after HFRS. Moreover, this condition is rare in clinical settings, with fever being the initial indication. For diseases with unknown origin such as refractory fever and diarrhea, it is crucial to differentiate them from common pathogenic infection and HV infections to provide timely treatment that improves the prognosis of patients.
Identifiants
pubmed: 37188347
doi: 10.4269/ajtmh.23-0078
pii: tpmd230078
pmc: PMC10323993
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
101-104Références
Clin Microbiol Infect. 2019 Apr;21S:e6-e16
pubmed: 24750436
Viruses. 2019 Jul 04;11(7):
pubmed: 31277410
Thromb Res. 2010 Aug;126(2):154-8
pubmed: 20579693
Emerg Infect Dis. 2010 Aug;16(8):1195-203
pubmed: 20678311
Virol Sin. 2017 Feb;32(1):32-43
pubmed: 28120221
J Clin Virol. 2017 Jun;91:25-30
pubmed: 28411480
Viruses. 2021 Aug 06;13(8):
pubmed: 34452419
Euro Surveill. 2011 Sep 08;16(36):
pubmed: 21924118
J Infect. 2016 Feb;72(2):253-5
pubmed: 26493271
Infect Drug Resist. 2022 Nov 23;15:6755-6761
pubmed: 36447788
Lancet. 1984 Nov 3;2(8410):1036-7
pubmed: 6149414
TH Open. 2018 Aug 27;2(3):e261-e264
pubmed: 31249949
Immunol Rev. 2008 Oct;225:163-89
pubmed: 18837782
BMC Infect Dis. 2020 Feb 4;20(1):103
pubmed: 32019494
Am J Trop Med Hyg. 2021 Feb 16;104(4):1432-1434
pubmed: 33591937
Epidemiol Infect. 2020 Oct 02;148:e248
pubmed: 33004084
J Infect Dis. 2015 Oct 1;212(7):1061-9
pubmed: 25762786
Rev Bras Ter Intensiva. 2007 Dec;19(4):494-8
pubmed: 25310170
BMC Infect Dis. 2020 Jan 13;20(1):36
pubmed: 31931740